[
  {
    "ts": null,
    "headline": "Hologic Inc. stock underperforms Friday when compared to competitors",
    "summary": "Hologic Inc. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=a7ce9ad2412a1b855ec3361bd99ec6428c864921053500645766f00b28e3ff4a",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752254160,
      "headline": "Hologic Inc. stock underperforms Friday when compared to competitors",
      "id": 135990916,
      "image": "",
      "related": "HOLX",
      "source": "MarketWatch",
      "summary": "Hologic Inc. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=a7ce9ad2412a1b855ec3361bd99ec6428c864921053500645766f00b28e3ff4a"
    }
  },
  {
    "ts": null,
    "headline": "Chlamydia Market Analysis and Forecast, 2025-2035 Featuring ActivBiotics, Bausch Health, Allergan, WCG Clinical, Hologic, Evofem, CRMI, Meridian Bioscience, Pfizer",
    "summary": "The global chlamydia market is projected for significant growth driven by rising chlamydia infections, with 127 million new cases annually, as per the World Health Organization. Key factors boosting the market include the adoption of advanced diagnostics like Nucleic Acid Amplification Tests (NAATs) and Point-of-Care Testing (POCT), alongside public health initiatives increasing awareness and screening. Challenges such as asymptomatic cases, social stigma, and antibiotic resistance persist, but",
    "url": "https://finnhub.io/api/news?id=d300f678f8e97ab13bc337dc9670e5860da1f892d5a59ee4841a8546fd357344",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752221220,
      "headline": "Chlamydia Market Analysis and Forecast, 2025-2035 Featuring ActivBiotics, Bausch Health, Allergan, WCG Clinical, Hologic, Evofem, CRMI, Meridian Bioscience, Pfizer",
      "id": 135879866,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "The global chlamydia market is projected for significant growth driven by rising chlamydia infections, with 127 million new cases annually, as per the World Health Organization. Key factors boosting the market include the adoption of advanced diagnostics like Nucleic Acid Amplification Tests (NAATs) and Point-of-Care Testing (POCT), alongside public health initiatives increasing awareness and screening. Challenges such as asymptomatic cases, social stigma, and antibiotic resistance persist, but",
      "url": "https://finnhub.io/api/news?id=d300f678f8e97ab13bc337dc9670e5860da1f892d5a59ee4841a8546fd357344"
    }
  }
]